Schedule 13G ownership disclosure

Phathom Pharmaceuticals Inc

Security class unavailable · CUSIP: 71722W107

Event date: 2024-10-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,993,422
Percent of class
10.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000053417-24-000085
Form type
SC 13G
Filer
JENNISON ASSOCIATES LLC
CIK
CIK 53417
Filed
Nov 04, 2024
Reporting period
Oct 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub